Roles
- Assistant Professor of Clinical Medicine
- Co-Leader for the Computational Oncology Research Lab in the Myeloma Institute
-
Biography
David Coffey, M.D., is an Assistant Professor of Medicine in the Division of Myeloma at the University of Miami’s Sylvester Comprehensive Cancer Center. His research focuses on developing precision medicine tools for multiple myeloma by translating genomic assays into clinically actionable insights. With expertise in computational oncology, data science, and machine learning, he studies tumor biology in the context of the immune microenvironment. His prior research has leveraged single-cell profiling, immune receptor sequencing, genomic analyses, and ex vivo drug testing to uncover immune responses, mechanisms of resistance, and predictors of therapeutic outcome. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Research Interests
David Coffey, M.D. is a computational oncologist specializing in the study and treatment multiple myeloma, a blood cancer affecting the antibody-producing plasma cells. His research investigates how multiple myeloma cancer cells interact with the body’s immune system. By utilizing advanced multi-omic single-cell analyses of the immune system alongside DNA sequencing of tumor cells, he aims to uncover why the immune system may sometimes fail to stop myeloma from progressing. Through this work, Dr. Coffey seeks to identify innovative strategies to empower the immune system to eliminate myeloma more effectively. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Articles & News
Sylvester Comprehensive Cancer Center Researchers Highlight Progress in Myeloma Treatment
What Makes Immunotherapy Work for Multiple Myeloma?
Immune System Plays Vital Role in Longer Multiple Myeloma Remission
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.